MedTrace Logo

Prenatal Probiotic Intervention

NCT03240419 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-01-18

No results posted yet for this study

Summary

This study will assess the feasibility of a randomized control trial in which the effects of probiotic supplementation throughout pregnancy on maternal insulin sensitivity and inflammation, as well offspring gene expression and body composition are examined.

Conditions

Interventions

DIETARY_SUPPLEMENT

Probiotics

Bifidobacterium BB12 and Lactobacillus Rhamosus LGG (50%:50%) capsules.

DIETARY_SUPPLEMENT

Placebo

capsule manufactured to mimic probiotic capsules.

Sponsors & Collaborators

  • Arkansas Children's Hospital Research Institute

    lead OTHER

Principal Investigators

  • Eva C Diaz Fuentes, MD · University of Arkansas

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-23
Primary Completion
2019-03-26
Completion
2019-03-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03240419 on ClinicalTrials.gov